Pharmacokinetic Study of Intravesical Gemcitabine in Carcinoma in situ of the Bladder Refractory to Bacillus Calmette-Guérin Therapy

Publisher： Karger

E-ISSN： 1423-0399|75|4|309-313

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.75, Iss.4, 2005-12, pp. : 309-313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bacillus Calmette-Guérin versus Gemcitabine for Intravesical Therapy in High-Risk Superficial Bladder Cancer: A Randomised Prospective Study

By  

Urologia Internationalis, Vol. 84, Iss. 1, 2010-02 ,pp. : 23-27

Karger

Access to resources Recommend Favorite

Vesicoureteral Reflux after Intravesical Instillation of Bacillus Calmette-Guérin against Carcinoma in situ of the Bladder

By  

Urologia Internationalis, Vol. 73, Iss. 3, 2004-11 ,pp. : 287-288

Karger

Access to resources Recommend Favorite

Intravesical Bacillus Calmette-Guérin Therapy for T1 Superficial Bladder Cancer

By  

Urologia Internationalis, Vol. 80, Iss. 1, 2008-01 ,pp. : 74-79

Karger

Access to resources Recommend Favorite

Recurrence and Progression of T1G3 Transitional Cell Carcinoma of the Bladder Treated with Intravesical Bacillus Calmette-Guérin

By  

Urologia Internationalis, Vol. 75, Iss. 2, 2008-07 ,pp. : 107-113

Karger

Access to resources Recommend Favorite

Cytological Changes Induced by Intravesical Bacillus Calmette-Guérin Therapy for Superficial Bladder Cancer

By  

Urologia Internationalis, Vol. 64, Iss. 2, 2000-05 ,pp. : 74-81

Karger

Access to resources Recommend Favorite